University of California, San Francisco |
June 27, National HIV Testing Day, is an opportunity for patients and clinicians alike to play a pivotal role by promoting widespread HIV testing. In recognition of the importance of testing, the Clinician Consultation Center is sharing a testing-related case from its HIV/AIDS Management Consultation Service, which celebrates its 25th birthday this year! Case Summary […]
Case of the Month: HIV-Positive Partner PrEP
Case Summary A 19-year-old male recently presented to the caller’s clinic requesting to start pre-exposure prophylaxis (PrEP). The patient reported having unprotected insertive and receptive anal intercourse with his HIV-positive partner for the past two months. His partner is on antiretroviral therapy, with the most recent HIV viral load at reportedly 500 copies/mL “a few […]
Case of the Month: HIV Testing in Newborns
Case Summary A neonatologist called about a very low birth weight (1134g) infant born at 37.5 weeks gestation to a 27-year-old woman who had been diagnosed with HIV at week 13 of her pregnancy. The mother had been started on co-formulated zidovudine/lamivudine (Combivir) and boosted lopinavir (Kaletra), and had achieved viral suppression at week 33 […]
National Women and Girls HIV/AIDS Awareness Day: CCC Resources
The Clinician Consultation Center (CCC) continues to support efforts to raise awareness around HIV prevention and care issues as they affect women and girls. As a national service of the Health Resources and Services Administration’s AIDS Education and Training Centers program, with support from the Centers for Disease Control and Prevention, the CCC provides personalized […]
Case of the Month: Transitioning from PEP to PrEP
Case Summary A physician called the PrEPline about a 43-year-old female sex worker who had vaginal receptive intercourse with a man approximately one month ago. Although a condom was used, it broke; the man subsequently disclosed he was HIV-positive. The patient presented to a community clinic within 24 hours of the incident and was started […]
Case of the Month: Initiating Hepatitis C Treatment in an HIV Co-Infected Patient
Case Summary A clinical pharmacist called the CCC regarding a 49 year-old male diagnosed with HIV and hepatitis C (HCV) in 2006. He was started on co-formulated tenofovir DF (TDF)/emtricitabine/efavirenz shortly after diagnosis but then stopped taking it in 2013 after falling out of care. The patient presented in early 2015 to re-engage in care, […]
Case of the Month: Opioid Use and HIV Management During Pregnancy
This month, we feature a case from the Substance Use Warmline, our new clinician-to-clinician telephone consultation service focusing on substance use evaluation and management for primary care clinicians. This case, Opioid Use and HIV Management During Pregnancy, was authored by Joanna Eveland, MS, MD, with contributions from Lealah Pollock, MD, James Gasper, PharmD, and Cristina […]
World AIDS Day 2015: Acting Now to End AIDS
World AIDS Day reminds us that while we have come far in the prevention and management of HIV, we still have progress to make as we strive toward an AIDS-free generation. This year’s federal theme, The Time to Act is Now, urges providers to engage with at-risk and HIV-positive patients on all points of the HIV Care […]
PEP Tips: Laboratory Cadaver Exposures
PEP Tips: Laboratory Cadaver Exposures A treating clinician assessing the risk of transmission for a person stuck by an instrument while handling or studying a cadaver in a laboratory setting should first check for documentation of the cadaver’s bloodborne pathogen (BBP) status. Organ procurement and transplant policy requires that all potential deceased organ donors are […]
Case of the Month: PEP Management and Kidney Disease
Case Summary The Clinician Consultation Center received a call from an occupational health provider caring for a physician who had just been stuck with a needle used to perform an arthrocentesis on a known HIV-positive source patient (SP). The SP was taking combination antiretroviral therapy which consisted of co-formulated abacavir/lamivudine (Epzicom®) and efavirenz (Sustiva®). The […]